Literature DB >> 12434900

Enuresis, sleep and desmopressin treatment.

T Nevéus1, G Bader, U Sillén.   

Abstract

AIM: To detect effects of desmopressin on sleep in enuretic children and to look for polysomnographical differences between responders and non-responders to desmopressin treatment.
METHODS: Twenty-one children with primary nocturnal enuresis were examined polysomnographically before treatment. All but one of the children then received treatment with desmopressin in standard dosage, and the response was documented. Seven of the children underwent a second polysomnographic registration while on treatment.
RESULTS: The time interval (+/- 1 SD) between sleep onset and the enuretic episode was 92 +/- 67 min without medication and 372 +/- 157 min when desmopressin was given (p = 0.003). Standard polysomnographic variables were not affected by the drug. Ten children were desmopressin responders and 10 were non-responders. The total sleep time was 455 +/- 56 min in the former and 408 +/- 31 min in the latter group (p = 0.04). The responders spent 27.4 +/- 5.5% of their total sleep time in rapid eye movement sleep, compared with 18.2 +/- 6.5% in the non-responder group (p = 0.004).
CONCLUSION: Desmopressin has no major effects on sleep as such but does delay bladder emptying. Enuretic children responding to desmopressin treatment have more rapid eye movement sleep than therapy-resistant children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434900     DOI: 10.1080/080352502760311647

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  [Primary monosymptomatic enuresis: diagnostics and therapy].

Authors:  J Seibold; S Alloussi; T Todenhöfer; A Stenzl; C Schwentner
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

2.  Enuresis nocturna and sleep quality.

Authors:  Salih Gozmen; Sukran Keskin; Ipek Akil
Journal:  Pediatr Nephrol       Date:  2008-05-28       Impact factor: 3.714

3.  The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis.

Authors:  Cuneyt Ozden; Ozdem Levent Ozdal; Binhan Kagan Aktas; Alper Ozelci; Serkan Altinova; Ali Memis
Journal:  Int Urol Nephrol       Date:  2008-03-05       Impact factor: 2.370

4.  Pitfalls in studies of children with monosymptomatic nocturnal enuresis.

Authors:  Johan Vande Walle; Erik Van Laecke
Journal:  Pediatr Nephrol       Date:  2007-12-04       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.